Luxembourg, January 19th, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s investment establishing ImmunoRx Pharma, Inc., a company based in Wilmington, Delaware. ImmunoRx Pharma, …
Kent Imaging Inc. is accelerating its growth through a US$15M investment by TVM Life Science Innovation II SCSp
CALGARY, AB, CANADA, January 13, 2021 /EINPresswire.com/ -- Kent Imaging, an innovator in the tissue imaging market, announced today its partnership with TVM Life Science Innovation II SCSp to …
Emovi and SIAwards: 2nd interview on KneeKG and knee pain
The interview was live just before the award to Lebron James! The interview also presents Dr Michael Suk, orthopedic surgeon and clinical expert Luis Zuniga, PT owner, talking about the KneeKG. Here …
Dentsply Sirona and Panthera Dental announce collaboration: fully digital workflow for custom-made sleep devices
(Charlotte/Quebec, November 12, 2020) Dentists now have the opportunity to use Primescan in a new area of application: Obstructive Sleep Apnea (OSA) and snoring, which affects up to 3.61 billion …
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm’s history
The Fund continues the proven “Project Focused Company” investment strategy for early-stage drug development candidates. In addition, the Fund continues to invest in late-stage clinical …
CENTOGENE Announces Leadership Transition
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world …
2022 TVM Capital Winter Conference
Dear Friends and Partners of TVM Capital Life Science. In light of the ongoing (COVID-19) coronavirus outbreak and the resulting travel restrictions, we have decided to postpone the TVM Winter …
CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases …
CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares
July 7, 2020 at 6:16 PM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases …
Centogene öffnet seine Labore für Coronatests
Verantwortung in Krisenzeiten: Ein Rostocker Unternehmen, das sonst seltenen Krankheiten auf der Spur ist, öffnet seine Labore für lebensrettende Coronatests. Bis zu 10.000 Abstriche können pro Tag …